A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

✍ Scribed by C.P. Thakur; T.P. Kanyok; A.K. Pandey; G.P. Sinha; A.E. Zaniewski; H.H. Houlihan; P. Olliaro

• Book ID: 108367479
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 366 KB
• Volume: 94
• Category: Article
• ISSN: 0035-9203
• DOI: 10.1016/s0035-9203(00)90130-5